Imatinib-Responsive Hypereosinophilia in a Patient with B Cell ALL

References

• Jaffe, E., Harris, L.H., Stein, H. and Vardiman, J.W. (2001) Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press.
   Google Scholar
• Brito-Babapulle, F. (2003) "The eosinophilias, including the idiopathic hypereosinophilic syndrome", Br. J. Haematol., 121, 203— 223.
   Web of Science ®Google Scholar
• Spiegel, R., Miron, D., Fink, D., Gavriel, H. and Horovitz, Y. (2004) "Eosinophilic pericarditis-a rare complication of idiopathic hypereosinophilic syndrome in a child", Pediatr. Cardiol., 00, 00 — 00.
   Google Scholar
• Lui, C.Y. and Makoui, C. (1988) "Severe constrictive pericarditis as an unsuspected cause of death in a patient with idiopathic hypereosinophilic syndrome and restrictive cardiomyopathy", Clin. Cardiol.,11, 502— 504.
   Web of Science ®Google Scholar
• Corssmit, E.P., Trip, M.D. and Durrer, J.D. (1999) "Loffler's endomyocarditis in the idiopathic hypereosinophilic syndrome", Cardiology, 91, 272–276.
   PubMed Web of Science ®Google Scholar
• Parrillo, J.E., Borer, JS., Henry, W.L., Wolff, S.M. and Fauci, A.S. (1979) "The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature", Am. J. Med., 67, 572–582.
   Google Scholar
• Simon, H.U., Plotz, S.G., Dummer, R. and Blaser, K. (1999) "Abnormal clones of T cells producing interleulcin-5 in idiopathic eosinophilia", N. Engl. J. Med., 341, 1112 — 1120.
   Google Scholar
• Brugnoni, D., Airo, P., Rossi, G., et al. (1996) "A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4 + T-cell population able to secrete large amounts of interleulcin-5", Blood, 87, 1416–1422.
   PubMed Web of Science ®Google Scholar
• Kitano, K., Ichikawa, N., Mahbub, B., et al. (1996) "Eosinophilia associated with proliferation of CD(3 + )4-(8-) alpha beta + T cells with chromosome 16 anomalies", Br. J. Haematol., 92, 315 — 317.
   Web of Science ®Google Scholar
• Schaller, J.L. and Burkland, GA. (2001) "Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate", MedGenMed., 3, 9.
   Google Scholar
• Cools, J., DeAngelo, DJ., Gotlib, J., et al. (2003) "A tyrosine lcinase created by fusion of the PDGFRA and FIPILI genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome", N. Engl. J. Med., 348, 1201 — 1214.
   Google Scholar
• Spitzer, G. and Garson, O.M. (1973) "Lymphoblastic leukemia with marked eosinophilia: a report of two cases", Blood, 42, 377— 384.
   PubMed Web of Science ®Google Scholar
• Fishel, R.S., Farnen, J.P., Hanson, CA., Silver, S.M. and Emerson, S.G. (1990) "Acute lymphoblastic leukemia with eosinophilia", Medicine (Baltimore), 69, 232–243.
   Google Scholar
• Troxell, ML., Mills, G.M. and Allen, R.C. (1984) "The hyper-eosinophilic syndrome in acute lymphocytic leukemia", Cancer, 54, 1058–1061.
   Google Scholar
• Bergeron, A., Bergot, E., Vilela, G., et al. (2002) "Hypersensitivity pneumonitis related to imatinib mesylate", J. Clin. Oncol., 20, 4271 —4272.
   Web of Science ®Google Scholar
• Henderson, ES., Scharlau, C., Cooper, MR., et al. (1979) "Combination chemotherapy and radiotherapy for acute lympho-cytic leukemia in adults: results of CALGB protocol 7113", Leuk. Res., 3, 395 — 407.
   Google Scholar
• Larson, R.A. (2000) "Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B", Hematol. Oncol. Clin. North Am., 14, 1367 —1379, x.
   Google Scholar
• Klion, A.D., Noel, P., Akin, C., et al. (2003) "Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness", Blood, 101, 4660 — 4666.
   Google Scholar
• Gleich, G.J., Leiferman, KM., Pardanani, A., Tefferi, A. and Butterfield, J.H. (2002) "Treatment of hypereosinophilic syndrome with imatinib mesilate", Lancet, 359, 1577–1578.
   Google Scholar
• Pardanani, A., Reeder, T., Porrata, L.F., et al. (2003) "Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders", Blood, 101, 3391–3397.
   Google Scholar
• Klion, A.D., Robyn, J., Akin, C., et al. (2004) "Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome", Blood, 103, 473–478.
   Google Scholar
• Samoszuk, M. and Nansen, L. (1990) "Detection of interleulcin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia", Blood, 75, 13–16.
   PubMed Web of Science ®Google Scholar
• Sanderson, C.J. (1992) "Interleulcin-5, eosinophils, and disease", Blood, 79, 3101–3109.
   PubMed Web of Science ®Google Scholar
• Narayanan, G., Hussain, B.M., Chandralekha, B., Sivasankar, C. and Nair, M.K. (2000) "Hypereosinophilic syndrome in acute lymphoblastic leukaemia —case report and literature review", Ada Oncol., 39, 241–243.
   Google Scholar
• Jain, P., Kumar, R., Gujral, S., et al. (2000) "Granular acute lymphoblastic leukemia with hypereosinophilic syndrome", Ann. Hematol., 79, 272–274.
   Web of Science ®Google Scholar
• Nunez, C.A., Zipf, T.F., Roberts, W.M., et al. (2003) "Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia", Arch. Pathol. Lab. Med., 127, 601 — 605.
   Web of Science ®Google Scholar
• Wynn, T.T., Heerema, NA., Hammond, S., Ranalli, M. and Kahwash, S.B. (2003) "Acute lymphoblastic leukemia with hyper-eosinophilia: Report of a case with 5q deletion and review of the literature", Pediatr. Dev. Pathol., 00, 00–00.
   Google Scholar
• Hogan, T.F., Koss, W., Murgo, A.J., et al. (1987) "Acute lymphoblastic leukemia with chromosomal 5;14 translocation and hypereosinophilia: case report and literature review", J. Clin. Oncol., 5, 382 — 390.
   Web of Science ®Google Scholar
• Baumgarten, E., Wegner, RD., Fengler, R., et al. (1989) "Calla-positive acute leukaemia with t(5q;14q) translocation and hyper-eosinophilia — a unique entity?", Acta Haematol., 82, 85–90.
   PubMed Web of Science ®Google Scholar
• Grimaldi, J.C. and Meeker, T.C. (1989) "The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleulcin-3 gene to the immunoglobulin heavy chain gene", Blood, 73, 2081–2085.
   PubMed Web of Science ®Google Scholar
• Meeker, T.C., Hardy, D., Willman, C., Hogan, T. and Abrams, J. (1990) "Activation of the interleulcin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia", Blood, 76, 285–289.
   PubMed Web of Science ®Google Scholar
• Apperley, J.F., Gardembas, M., Melo, J.V., et al. (2002) "Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta", N. Engl. J. Med., 347, 481–487.
   Google Scholar
• Wilkinson, K., Velloso, ER., Lopes, L.F., et al. (2003) "Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib", Blood, 102, 4187–4190.
   PubMed Web of Science ®Google Scholar